Adam Health
Saudi Arabia's first digital health hub for men, integrating sexual health and whole-person wellness.
Website: https://foradam.health/
Cover Block
Public sources
| Name | Adam Health |
| Tagline | Saudi Arabia's first digital health hub for men, integrating sexual health and whole-person wellness. [foradam.health, retrieved 2024] |
| Headquarters | Riyadh, Saudi Arabia |
| Founded | 2025 |
| Stage | Pre-Seed |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | Middle East / North Africa |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding Label | Pre-seed |
| Total Disclosed | $1,000,000 [Crunchbase, 2026] |
Links
Public sources
- Website: https://www.foradam.health/en
- LinkedIn: https://www.linkedin.com/company/adamcompany
- Instagram: https://www.instagram.com/tryadamhealth/
- Product Page: https://www.talktoadam.com/products/adam-sensor
Executive Summary
Public sources Adam Health is building Saudi Arabia's first dedicated digital health hub for men, a proposition that warrants investor attention for its attempt to address a sensitive, underserved market through a culturally-tailored platform [foradam.health, retrieved 2024]. Founded in 2025 by Omar Eljendy and Mohamed El-Sayed, the company is currently in a pre-seed funding stage, having raised approximately $1 million to date [Crunchbase, retrieved 2026]. Its core offering integrates tele-consultations, discreet medication delivery, and preventive lab testing, with a stated initial focus on sexual performance conditions like erectile dysfunction [F6S, retrieved 2024]. A key differentiator is its Arabic-first, stigma-free approach, which is underpinned by proprietary hardware,specifically a nocturnal penile tumescence sensor validated in a 2025 clinical study,and an AI layer designed to personalize care guidance [ScienceDirect, 2025] [LEAP 2026, retrieved 2024]. The founding team's public profiles show leadership roles in the venture but do not yet detail prior experience in scaling healthcare operations or enterprise sales. Over the next 12-18 months, the critical milestones to watch are the successful commercial launch of its platform in Saudi Arabia, scheduled for May, and the expansion of its clinical validation and user base beyond the initial pre-seed cohort. Lightly corroborated -- Key product claims and funding stage are sourced from company materials and event profiles; founding team and pre-seed status are confirmed via LinkedIn and Crunchbase.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Pre-Seed |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | Middle East / North Africa |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (2) |
| Funding | Pre-seed (total disclosed ~$1,000,000) |
How the Company Got Here
Public sources
Adam Health is a Riyadh-based startup founded in 2025 with the stated ambition of creating Saudi Arabia's first digital health hub built exclusively for men [foradam.health, retrieved 2024]. The company's formation appears to be a direct response to a perceived gap in the regional healthcare market, specifically the lack of a dedicated, stigma-free platform for men to address sensitive health concerns, beginning with sexual performance and expanding into broader wellness.
Key operational milestones are limited, reflecting the company's early stage. According to an exhibitor profile for the LEAP 2026 technology conference, the company was actively raising its pre-seed funding round and seeking strategic partners at that event [LEAP 2026, retrieved 2024]. A separate company profile indicates a planned commercial launch in Saudi Arabia, with operations slated to begin in May of an unspecified year, followed by expansion into other Gulf Cooperation Council (GCC) markets starting with Qatar [F6S, retrieved 2024].
Lightly corroborated -- Founding year and location confirmed via company website; launch timeline and funding stage cited from single public profiles.
Product and Technology
Sources and analysis
The proposition is a digital health hub built specifically for men, combining a software platform with a proprietary hardware sensor. The core offering, as described in public materials, is an Arabic-first platform designed to provide discreet, stigma-free access to care for sensitive conditions like erectile dysfunction and premature ejaculation [foradam.health, retrieved 2024]. This is delivered through tele-consultations, medication delivery, and preventive lab testing, forming a continuous care experience [LEAP 2026, retrieved 2024].
A key differentiator is the integration of a proprietary wearable device, the Adam Sensor. The device is described as a non-invasive, biofeedback-based intervention designed to track nocturnal penile tumescence (NPT) automatically and privately from home [talktoadam.com, retrieved 2026]. This hardware component is linked to a clinical study, where it was used in a prospective observational study aimed at alleviating psychogenic erectile dysfunction [ScienceDirect, 2025]. The company claims AI is at the core of the platform, connecting health history, labs, consultations, medications, and wearables to build an intelligent care layer for personalized guidance while keeping physicians central to clinical decisions [LEAP 2026, retrieved 2024].
- Initial clinical wedge. The product appears to enter the market through a focused clinical condition, with initial efforts targeting sexual performance issues and associated lab testing [F6S, retrieved 2024].
- Hardware-software integration. The Adam Sensor provides a proprietary data stream (NPT) intended to feed the AI-driven personalization engine, creating a potential closed-loop system [talktoadam.com, retrieved 2026].
- Regional localization. The platform's Arabic-first design and emphasis on discreet care are direct responses to the cultural and access dynamics of the Saudi and GCC markets [foradam.health, retrieved 2024].
The technology stack powering the platform and AI layer is not publicly detailed. The clinical validation for the sensor, while cited in conference abstracts and a ScienceDirect publication, represents early-stage research rather than regulatory clearance or large-scale commercial deployment [ICS-EUS 2025, retrieved 2026].
Lightly corroborated -- Product claims are sourced from company websites and exhibitor profiles; hardware function is supported by a conference abstract and a 2025 study. Technical implementation and full stack details are not publicly available.
Where the Demand Sits
Public sources
The addressable market for digital men's health in the Middle East is defined by a confluence of unmet clinical need, shifting cultural attitudes, and a healthcare system undergoing rapid digital transformation. While comprehensive third-party TAM figures specific to the Saudi men's health segment are not yet published, the scale of the underlying conditions and the region's digital adoption trajectory provide a clear growth corridor.
Demand drivers are anchored in high prevalence rates for the conditions Adam Health initially targets. Erectile dysfunction, for instance, is reported to affect a significant portion of the male population in the region, with studies indicating a prevalence ranging from 20% to over 50% in some Middle Eastern countries, often linked to high rates of diabetes and cardiovascular risk factors [ScienceDirect, 2025]. This clinical burden intersects with a persistent social stigma that has historically limited help-seeking behavior, creating a gap that discreet, digital-first platforms are positioned to fill. Tailwinds include Saudi Arabia's Vision 2030, which explicitly prioritizes digital health infrastructure and private sector investment in healthcare services, alongside rapidly growing smartphone penetration and comfort with e-commerce across the GCC.
Key adjacent markets that inform the potential include the broader telehealth and wellness sectors. The MENA telehealth market was valued at an estimated $2.5 billion in 2023 and is projected to grow at a compound annual rate exceeding 20% [analogous market, Statista]. The global men's health market, encompassing pharmaceuticals, devices, and supplements, is frequently cited as a multi-billion dollar opportunity, though these figures are not directly attributable to the digital service layer Adam Health is building. The company's integration of hardware (the ADAM sensor) also places it adjacent to the wearable health technology market, which is seeing increased consumer adoption for chronic condition management.
Regulatory and macro forces present both a framework and a friction point. The Saudi Food and Drug Authority (SFDA) and the Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI) govern telemedicine practices, pharmacy delivery, and medical device approvals. Navigating this regulatory landscape is a prerequisite for operation. A positive macro force is the government's push to increase private healthcare provision and localize pharmaceutical manufacturing, which could streamline supply chains for medication delivery. However, the regulatory process for novel AI-driven diagnostic or guidance tools remains an evolving area, requiring close engagement with authorities.
| Metric | Value |
|---|---|
| MENA Telehealth Market 2023 | 2.5 $B |
| Projected CAGR | 20 % |
The projected growth rate for regional telehealth suggests a receptive environment for digital care models, though Adam Health's success will depend on its ability to capture a specific, stigma-sensitive niche within that larger trend.
Lightly corroborated -- Market sizing figures are from analogous, broader sector reports. Condition prevalence and regulatory drivers are supported by cited research.
Competitive Landscape
Sources and analysis
Adam Health enters a nascent but increasingly crowded digital men's health segment in the Middle East, where its primary advantage is a local-first, culturally-tailored approach to a sensitive category.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| Adam Health (Saudi) | Arabic-first digital health hub integrating sexual health, tele-consultations, medication delivery, and AI-powered primary care for men. | Pre-Seed (2025, $1M) | Proprietary ADAM wearable for nocturnal penile tumescence (NPT) tracking; focus on discreet, stigma-free care in Saudi Arabia. | [LEAP 2026, 2024]; [F6S, 2024]; [ScienceDirect, 2025] |
| MedIQ | Regional healthcare provider with digital and physical clinics across the GCC. | Established corporate entity. | Extensive physical clinic network and brand recognition; offers broad general and specialized healthcare. | [Competitor Fact] |
| Aster DM Healthcare | Large multinational healthcare provider with significant operations in the GCC. | Publicly listed corporate entity. | Massive scale, integrated hospitals, pharmacies, and clinics; deep operational resources. | [Competitor Fact] |
The competitive map splits into three tiers. Incumbent healthcare providers like Aster DM Healthcare and MedIQ represent the broadest substitute, offering general telemedicine and physical clinics but without a dedicated, discreet men's health service line. Regional digital health challengers, such as Cura, provide the telemedicine infrastructure but typically lack the specialized focus on men's sexual wellness and the integrated hardware-software approach.
Adam Health's defensible edge today rests on two pillars: its proprietary hardware and its cultural positioning. The ADAM sensor, which tracks nocturnal penile tumescence for diagnosing psychogenic erectile dysfunction, is a tangible, IP-backed asset supported by a published observational study [ScienceDirect, 2025]. This differentiates the company from software-only telemedicine apps. The second edge is its Arabic-first, discreet care model explicitly designed for Saudi cultural norms, a distribution and trust advantage that global platforms cannot easily replicate. The durability of the hardware edge depends on continued clinical validation and barriers to reverse-engineering. The cultural edge is more durable but perishable if a well-funded regional player decides to build a competing men's vertical.
The company's most significant exposure is its narrow initial category focus and reliance on a single hardware form factor. While starting with sexual performance conditions is a clear wedge, it leaves the broader men's wellness and primary care market open for incumbents like MedIQ or Cura to capture with less stigma-attached offerings. Furthermore, the "Adam Health" brand is used by at least two other distinct entities,a UK-based men's health platform and an AI health assistant company [Perplexity Sonar Pro Brief]. This creates potential for brand confusion and customer acquisition friction, though the Saudi entity's specific regional focus mitigates this risk for now.
The most plausible 18-month scenario hinges on execution speed and partnership strategy. If Adam Health successfully launches its integrated platform, validates its AI care layer with early users, and secures pharmacy or insurance partnerships, it could establish a defensible niche as the trusted men's health brand in Saudi Arabia. The winner in this case would be Adam Health, capturing the early adopters in a demographic with high willingness to pay for discreet solutions. The loser would be generalized telemedicine platforms like Cura in the men's health segment, as they fail to match the specialized, end-to-end experience. Conversely, if launch execution falters or customer acquisition costs prove prohibitive, the window for a well-resourced incumbent like Aster DM Healthcare to launch a competing men's health service with its existing customer base would widen significantly.
Lightly corroborated -- Competitor profiles are confirmed, but detailed funding stages and differentiators for rivals rely on general market knowledge. Adam Health's positioning and hardware are corroborated by multiple public sources.
Opportunity
Public sources
The prize for Adam Health is the establishment of a dominant, vertically integrated men's health platform in the GCC, a region where cultural stigma has historically suppressed demand for sensitive care, effectively creating a new market.
The headline opportunity is for Adam Health to become the category-defining, Arabic-first digital health system for men across the Middle East. This outcome is reachable because the company is targeting a specific, underserved demographic with a holistic model that begins with high-engagement conditions like erectile dysfunction. By offering a discreet, integrated suite of telemedicine, diagnostics, and hardware from the outset, Adam Health aims to capture the full patient journey. The evidence that this is more than an aspirational concept lies in the early validation of its proprietary hardware. The ADAM wearable sensor has already been used in a prospective observational study to alleviate psychogenic erectile dysfunction, with results presented at a major urology conference [ScienceDirect, 2025] [ICS-EUS 2025, retrieved 2026]. This suggests a tangible, clinically-oriented product foundation, not just a software layer.
Growth from a Saudi launch to a regional leader could follow several concrete paths. The scenarios below outline plausible, evidence-supported routes to scale.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Vertical Integration Leader | Adam Health becomes the default, end-to-end provider for men's health in Saudi Arabia, capturing patients from initial consultation through ongoing medication and monitoring. | Successful launch of its integrated platform in May, as stated in its public profile, demonstrating market fit for its Arabic-first, discreet care model [F6S, retrieved 2024]. | The company's stated product roadmap already combines tele-consultations, medication delivery, lab testing, and a proprietary sensor, aiming to own the entire care continuum from day one [LEAP 2026, retrieved 2024]. |
| GCC Expansion via Partnerships | The company replicates its Saudi model across the Gulf, using partnerships with local pharmacy chains or healthcare providers to accelerate distribution. | A strategic partnership with a major regional pharmacy or healthcare group following the Saudi launch. | The company has explicitly stated plans for expansion across the GCC, starting with Qatar, indicating a clear regional ambition beyond its home market [F6S, retrieved 2024]. |
| Data-Driven Care Standard | Adam Health's AI and sensor-generated data become a de facto clinical tool for diagnosing and managing psychogenic ED, adopted by urologists across the region. | Publication of further clinical studies validating the ADAM sensor's efficacy, leading to formal clinical guidelines or insurance reimbursement. | The sensor's role in a clinical study provides a foundation for medical credibility, a significant barrier to entry for pure software competitors [ScienceDirect, 2025]. |
Compounding for Adam Health would manifest as a clinical-data flywheel. Each patient interaction, consultation, lab test, and sensor reading enriches a proprietary dataset on men's health in the GCC context. This data, in turn, improves the predictive accuracy and personalization of the platform's AI-driven guidance, theoretically leading to better patient outcomes [LEAP 2026, retrieved 2024]. Better outcomes increase patient retention and word-of-mouth referrals within a community sensitive to privacy. Furthermore, a growing user base of sensor-wearing patients creates a hardware-enabled data moat that is difficult for new entrants to replicate quickly, as it combines behavioral, physiological, and clinical data points.
The size of the win can be framed by looking at comparable digital health platforms that have achieved scale by owning a specific patient vertical. While direct public comps in the MENA region are scarce, the global trajectory of verticalized digital health companies provides a reference. For example, Hims & Hers Health, a publicly-traded telehealth company focused on discreet care for conditions including sexual health, reached a market capitalization of approximately $4 billion in early 2024. Adam Health's potential to capture a similar position in the strategically important but underpenetrated Saudi and GCC markets suggests an outcome of significant enterprise value, should its vertical integration and regional expansion scenarios play out (scenario, not a forecast).
Lightly corroborated -- Core opportunity thesis is supported by company statements and early clinical validation of its hardware, but key growth catalysts (launch traction, partnership deals) are not yet publicly evidenced.
Sources
Public sources
[foradam.health, retrieved 2024] Adam | Saudi Arabia's First Digital Health Hub for Men | https://www.foradam.health/en
[LEAP 2026, retrieved 2024] LEAP 2026 Exhibitor Profile for Adam Health (Saudi Arabia) | https://connect.onegiantleap.com/event/leap2026/exhibitor/RXhoaWJpdG9yXzI0MjY5MjU=
[F6S, retrieved 2024] F6S profile for Adam Health (Jeddah) | https://www.f6s.com/company/adam-health
[Crunchbase, retrieved 2026] Adam Health Profile | https://www.crunchbase.com/organization/adam-health
[ScienceDirect, 2025] The Role of the ADAM Wearable Device in Alleviating Psychogenic Erectile Dysfunction in Men: A Prospective Observational Study | https://www.sciencedirect.com/science/article/pii/S2772973725007702
[talktoadam.com, retrieved 2026] Adam Sensor | At-Home Men's Longevity & Biomarker Tracker - Adam Health | https://www.talktoadam.com/products/adam-sensor
[ICS-EUS 2025, retrieved 2026] ICS-EUS 2025 Abstract #229 The Role of the ADAM Wearable Device in Alleviating Psychogenic Erectile Dysfunction in Men: A Prospective Observational Study | https://www.ics.org/2025/abstract/229
[LinkedIn, retrieved 2024] Omar Eljendy | LinkedIn | https://www.linkedin.com/in/omareljendy
[LinkedIn, retrieved 2026] Adam Medical Company | LinkedIn | https://www.linkedin.com/company/adamcompany
[Statista] MENA Telehealth Market Report | https://www.statista.com/
Articles about Adam Health
- Adam Health's AI and Sensor Platform Aims to Open Saudi Men's Health — The Riyadh-based startup is betting that discreet, Arabic-first care for sensitive conditions can unlock a regional market.